<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04751864</url>
  </required_header>
  <id_info>
    <org_study_id>2503</org_study_id>
    <nct_id>NCT04751864</nct_id>
  </id_info>
  <brief_title>Brain Stimulation &amp; Generalized Anxiety Study</brief_title>
  <official_title>Fisher Wallace Brain Stimulation &amp; Generalized Anxiety Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProofPilot</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fisher Wallace</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ProofPilot</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator&#xD;
      (CES) Device on Generalized Anxiety Disorder using two (2) 20-minute per day treatment&#xD;
      sessions over eight weeks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">June 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants randomized into Sham and Active device arms for four weeks. At the week 5 crossover, participants in sham arm receive active device.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Beck Anxiety Inventory (BAI) Score</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>The Beck is a 21 item self-reported scale measuring anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Promise Sleep-SD</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>Change in self reported sleep quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Health Questionnaire - 8 (PHQ-8)</measure>
    <time_frame>baseline versus week 4</time_frame>
    <description>self reported depression symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Beck Anxiety Inventory (BAI) Score</measure>
    <time_frame>week 4 versus week 8</time_frame>
    <description>The Beck is a 21 item self-reported scale measuring anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device safety, tolerability and adherence as measured by SAFTEE</measure>
    <time_frame>baseline versus week 8</time_frame>
    <description>The SAFTEE is a self reported measure of side effects associated with mental health treatments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Anxiety</condition>
  <condition>Generalized Anxiety Disorder</condition>
  <condition>Generalized Anxiety</condition>
  <arm_group>
    <arm_group_label>Active Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive active device for the full 8 week study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Arm</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants receive sham device for the first 4 weeks, and then at the week 5 cross over, receive the active device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cranial Electrotherapy Stimulator (CES) Device</intervention_name>
    <description>Fisher Wallace Cranial Electrotherapy Stimulator (CES) Device</description>
    <arm_group_label>Active Arm</arm_group_label>
    <arm_group_label>Sham Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than 21&#xD;
&#xD;
          -  US resident&#xD;
&#xD;
          -  Can receive packages to their home via UPS/Fedex/USPS&#xD;
&#xD;
          -  Licensed Physician Diagnosis of Generalized Anxiety Disorder&#xD;
&#xD;
          -  Beck Anxiety Inventory Score between 8 and 25&#xD;
&#xD;
          -  Read/write English&#xD;
&#xD;
          -  Have not contemplated suicide in the past year&#xD;
&#xD;
          -  Not been institutionalized for mental health issues.&#xD;
&#xD;
          -  Not currently experiencing problems with alcohol or drug abuse&#xD;
&#xD;
          -  Can commit to not drinking alcohol 4 hours before bedtime for the duration of the&#xD;
             study&#xD;
&#xD;
          -  Can commit to two (2) 20 minute sessions per day for 8 weeks&#xD;
&#xD;
          -  Not under medical supervision for serious medical condition&#xD;
&#xD;
          -  Not currently being treated for or suspect a mental health issue&#xD;
&#xD;
          -  Has not used a brain stimulation treatment in one year&#xD;
&#xD;
          -  No suspected or known history of heart disease&#xD;
&#xD;
          -  No pacemaker, or any form of medical electronics, including but not limited to a deep&#xD;
             - brain stimulator, electronic stent, etc.&#xD;
&#xD;
          -  Not taking opioids&#xD;
&#xD;
          -  Are a resident of states in which we have licensed medical professionals&#xD;
&#xD;
          -  Does not have any co-occurring significant psychiatric disorder that would impair -&#xD;
             participant's particationion.&#xD;
&#xD;
          -  Does not use any illicit drugs&#xD;
&#xD;
          -  Not participating in any other anxiety study&#xD;
&#xD;
          -  Not taking medications affecting the nervous system (e.g. psychiatric medications)&#xD;
&#xD;
          -  Not taking hypnotics or any sleep aid or marijuana (in any form)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ProofPilot (Remote Virtual Trial)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

